Role of nintedanib in the treatment of progressive pulmonary fibrosis (PPF) in daily clinical practice.

被引：0
|
作者：
Andres Franch, Fatima [1 ]
Alvarez Martinez, Ignacio Salvador [2 ]
Andujar Llamazares, Mario [3 ]
Segura Ayala, Daniel [3 ]
Meneses Petersen, Elsie Daviana [1 ]
Cabanes Lopez, Luis [1 ]
Novella Sanchez, Laura [1 ]
Ferrando Gabarda, Jose Ramon [1 ]
Meseguer Sisternes, Maria [1 ]
Lluch Tortajada, Inmaculada [1 ]
Naval Sendra, Elsa [1 ]
机构：
[1] Hosp Univ La Ribera, Resp Med Unit, Alzira, Valencia, Spain
[2] Hosp Univ La Ribera, Internal Med Unit, Alzira, Valencia, Spain
[3] Hosp Gen Univ Castellon, Resp Med Unit, Castellon de La Plana, Spain
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA407
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Pirfenidone and Nintedanib for Treatment of Idiopathic Pulmonary Fibrosis
    Sathiyamoorthy, Gayathri
    Sehgal, Sameep
    Ashton, Rendell W.
    SOUTHERN MEDICAL JOURNAL, 2017, 110 (06) : 393 - 398
  • [22] Nintedanib (OFEV) in the treatment of idiopathic pulmonary fibrosis
    Fukihara, Jun
    Kondoh, Yasuhiro
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (12) : 1247 - 1254
  • [23] Treatment of idiopathic pulmonary fibrosis with Nintedanib: an update
    Wongkarnjana, Amornpun
    Yanagihara, Toyoshi
    Kolb, Martin R. J.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (12) : 1139 - 1146
  • [24] Association of Quantitative Lung Fibrosis ( QLF) Score With the Severity and Progression of Progressive Pulmonary Fibrosis (PPF)
    Swaminathan, A. C.
    Whelan, T. P. M.
    Neely, M. L.
    Todd, J. L.
    Palmer, S. M.
    Weber, J. M.
    Kim, G. J.
    Li, P.
    Leonard, T. B.
    Conoscenti, C. S.
    Goldin, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [25] NINTEDANIB FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS - INITIAL CLINICAL EXPERIENCE IN A UK COHORT
    Fletcher, S. V.
    Jones, M. G.
    Renzoni, E.
    Parfrey, H.
    Hoyles, R.
    Spinks, K.
    Kokosi, M.
    Kwok, A.
    Warburton, C.
    Titmuss, V.
    Maher, T.
    Chua, F.
    Wells, A.
    Richeldi, L.
    Spencer, L. G.
    THORAX, 2015, 70 : A78 - A78
  • [26] Nintedanib in Progressive Pulmonary Fibrosis A Systematic Review and Meta-Analysis
    Ghazipura, Marya
    Mammen, Manoj J.
    Herman, Derrick D.
    Hon, Stephanie M.
    Bissell, Brittany D.
    Macrea, Madalina
    Kheir, Fayez
    Khor, Yet H.
    Knight, Shandra L.
    Raghu, Ganesh
    Wilson, Kevin C.
    Hossain, Tanzib
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (06) : 1040 - 1049
  • [27] Nintedanib in progressive Non-IPF-Pulmonary Fibrosis - A Subgroup Analysis
    Markart, Philipp
    PNEUMOLOGE, 2020, 17 (05): : 350 - 351
  • [28] Clinical implications of nintedanib pharmacokinetics in patients with pulmonary fibrosis
    Agema, B. C.
    Berrich, M.
    Seuren, L.
    Sassen, S. D. T.
    Miedema, J. R.
    Koch, B. C. P.
    Wijsenbeek, M. S.
    Koolen, S. L. W.
    Mathijssen, R. H. J.
    Veerman, G. D. M.
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 179
  • [29] Remission of psoriasis with nintedanib for the treatment of idiopathic pulmonary fibrosis
    Murata, Akari
    Watanabe, Satoshi
    Ikawa, Yuka
    Saeki, Keigo
    Yamamura, Kenta
    Matsuoka, Hiroki
    Tanimura, Kota
    Tambo, Yuichi
    Kasahara, Kazuo
    JOURNAL OF DERMATOLOGY, 2019, 46 (04): : E118 - E119
  • [30] Combination Nintedanib and Pirfenidone for Treatment of Idiopathic Pulmonary Fibrosis
    Rajchgot, Jason
    Stanbrook, Matthew B.
    Anand, Anju
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 198 (08) : 1105 - 1105
12345